If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
275.20    2.40 (0.88%)
Bid:
274.60
Ask:
275.60
Spread: 1.00 (0.364%)
Market Cap: £693.71m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Director/PDMR Shareholding

7 May 2021 17:23

RNS Number : 9888X
Genuit Group PLC
07 May 2021
 

Genuit Group plc (the "Company")

 

Notification of transactions by Person Discharging Managerial Responsibilities

 

The Company announces that on 4 May 2021, Glen Sabin, Chief Operating Officer and a Person Discharging Managerial Responsibilities, exercised the following options:

 

1. a nil-cost option over 18,376 shares in accordance with the Long Term Incentive Plan Award granted to him on 2 May 2018. Mr. Sabin sold all exercised shares with the appropriate tax and national insurance liabilities deducted from the sale proceeds.

 

2. a nil-cost option over a total of 1,537 shares (comprising 1,482 shares granted under the Award and 55 shares awarded at vesting in lieu of dividends paid during the vesting period) in accordance with the Deferred Share Bonus Plan Award granted to him on 2 May 2018. Mr. Sabin sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

 

3. a nil-cost option over a total of 4,141 shares (comprising 4,027 shares granted under the Award and 114 shares awarded at vesting in lieu of dividends paid during the vesting period) in accordance with the Deferred Share Bonus Plan Award granted to him on 30 April 2019. Mr. Sabin sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

 

Mr. Sabin now holds an interest in a total of 716,574 shares.

 

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Glen Sabin

2

Reason for the notification

a)

Position/status

Chief Operating Officer/Director and PDMR

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Genuit Group plc

b)

LEI

2138005IF1N2RKJ6KO18

 

 

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares ("Shares") of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

b)

Nature of the transaction

Sale of Shares acquired for no consideration pursuant to the exercise of nil-cost options in accordance with the Long Term Incentive Plan ("LTIP") award granted on 2 May 2018.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£5.68

18,376

 

 

d)

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

18,376

 

 

£5.68

e)

Date of the transaction

6 May 2021

f)

Place of the transaction

Outside a Trading Venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Glen Sabin

2

Reason for the notification

a)

Position/status

Chief Operating Officer/Director and PDMR

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Genuit Group plc

b)

LEI

2138005IF1N2RKJ6KO18

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares ("Shares") of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

b)

Nature of the transaction

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options as follows: Deferred Share Bonus Plan ("DSBP") award granted on 2 May 2018.

Deferred Share Bonus Plan ("DSBP") award granted on 30 April 2019.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

Nil

818 - Number of DSBP shares acquired from

2 May 2018 grant after reduction for appropriate tax and national insurance liabilities.

 

 

 

 

 

 

2,204 - Number of DSBP shares acquired from 30 April 2019 grant after reduction for appropriate tax and national insurance

liabilities.

 

 

d)

Aggregated information

 

 

- Aggregated volume

 

 

- Price

N/A

e)

Date of the transaction

6 May 2021

f)

Place of the transaction

Outside a Trading Venue

 

 

Enquiries:

 

Emma Versluys, Company Secretary

+44 (0) 1709 770 000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKOBBABKDDPK
Date   Source Headline
7th Oct 20244:05 pmRNSHolding(s) in Company
9th Sep 20245:13 pmRNSHolding(s) in Company
6th Sep 20244:46 pmRNSHolding(s) in Company
20th Aug 20244:26 pmRNSDirector/PDMR Shareholding
13th Aug 20247:00 amRNSHalf-year Report
8th Aug 20247:00 amRNSBlue green roof & underfloor heating acquisitions
7th Aug 20247:00 amRNSAppointment of Joint Corporate Broker
10th Jun 20244:34 pmRNSHolding(s) in Company
10th Jun 20244:32 pmRNSHolding(s) in Company
28th May 20242:14 pmRNSResult of AGM
28th May 20247:00 amRNSTrading Update
2nd May 20244:57 pmRNSBlock listing Interim Review
24th Apr 202410:39 amRNSNotice of AGM
10th Apr 20244:24 pmRNSDirector/PDMR Shareholding
10th Apr 20244:17 pmRNSDirector/PDMR Shareholding
9th Apr 20244:28 pmRNSDirector Declaration
2nd Apr 20243:56 pmRNSDirector/PDMR Shareholding
20th Mar 20243:27 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFinal Results
1st Mar 20248:30 amRNSDirector Declaration
19th Feb 20249:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20243:49 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSStrategy Progress Update Notification
15th Nov 20237:00 amRNSTrading Update
9th Nov 202310:08 amRNSDirector Declaration
2nd Nov 202311:59 amRNSDirector/PDMR Shareholding
1st Nov 20234:00 pmRNSBlock listing Interim Review
1st Nov 20237:00 amRNSDirectorate Change
25th Oct 20234:04 pmRNSDirector/PDMR Shareholding
17th Oct 20234:05 pmRNSDirector/PDMR Shareholding
11th Oct 20233:25 pmRNSDirector/PDMR Shareholding
6th Oct 20233:59 pmRNSDirector/PDMR Shareholding
11th Sep 202312:56 pmRNSDirector/PDMR Shareholding
1st Sep 20239:30 amRNSInterim Chief Financial Officer appointment
23rd Aug 20231:34 pmRNSDirector/PDMR Shareholding
18th Aug 202312:14 pmRNSDirector/PDMR Shareholding
16th Aug 202311:42 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSHalf-year Report
27th Jun 202312:01 pmRNSDirector/PDMR Shareholding
12th Jun 20234:11 pmRNSDirectorate Change
6th Jun 20237:00 amRNSDirectorate Change
18th May 202311:40 amRNSResult of AGM
18th May 20237:00 amRNSTrading Update
2nd May 20239:38 amRNSBlock listing Interim Review
25th Apr 20234:19 pmRNSDirector/PDMR Shareholding
25th Apr 20234:16 pmRNSDirector/PDMR Shareholding
18th Apr 202310:49 amRNSNotice of AGM
13th Apr 20233:57 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSDirectorate Change
31st Mar 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.